The social giant is raising $95 billion through stock-linked deals into early 2025, and the chip trio could buy into a $35 billion offering.

The AI startup sits atop a pyramid of partners and suppliers, so its public debut will ripple far beyond one stock.

CEO Minami Maeda is running Phase 3 trials and targeting a 2028 FDA submission as photoimmunotherapy moves from Japanese clinics toward the world's largest market.

Authentic Brands Group's suit over Presley's catalog signals a new front in AI copyright battles.

The quiet data transfer hands Musk's company an orbital tracking edge, raising national security and competition alarms.

New Monster data shows loyal employees are walking out silently over culture, not pay, and teams are paying the price.

A rout in neocloud stocks is forcing investors to weigh Nvidia's hidden exposure as both supplier and lender to the AI buildout.

The card giant is betting AI will let it run leaner, but the restructuring charge hits right as investors digest Q3 results.

The Oculus and Anduril founder is betting $200 million that 'elite working dogs' with advanced body armor will reshape the battlefield.

Flanagan and King extend the story beyond the prom after a 105-country No. 1 debut.

Ranking member Robert Garcia demands documents on Eric Baker's Andro Capital ties, warning of conflicts that could raise ticket costs and squeeze artists.

The automaker is using artificial intelligence to compress product development and answer fast-moving Chinese rivals.